HypertensionBENEFIT-HNCT06195839
Building Engagement Using Financial Incentives Trial - Hypertension
A study testing Remote Patient Monitoring, Self-monitoring of hypertension-related factors and Immediate financial incentives in people with Hypertension and Health Behavior, run by Tulane University at 2 sites in United States.
Trial summary
The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQHCs). Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Hypertension, Health Behavior, Healthcare Patient Acceptance
- What is being tested?
- Remote Patient Monitoring, Self-monitoring of hypertension-related factors and Immediate financial incentives
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 2 sitesUnited States
- Study dates
- 22 May 2024to 11 Sep 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥40 years
- receive care at a participating FQHC
- taking blood pressure medication
- uncontrolled blood pressure at most recent clinic visit (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg)
- ability to understand and speak English
- able to access a smartphone
Who cannot join
- currently participating in another clinical trial or research study on blood pressure, medication-taking, or sleep
- unable or unwilling to give informed consent
Trial locations and contacts
2 sites in 1 country.
United States2 sites
CommuniHealth Services
Bastrop, Louisiana, 71220
David Raines Community Health Center
Shreveport, Louisiana, 71107
About this study
The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQHCs). The main questions it aims to answer are:
- Do patients randomized to receive financial incentives on a weekly basis during the study (immediate) have better adherence to blood pressure self-monitoring compared to patients randomized to receive financial incentives at the end of the study (delayed)?
- Do patients randomized to immediate financial incentives have better blood pressure control compared to patients randomized to delayed incentives?
Read more
Participants will:
- attend a baseline visit to measure blood pressure, respond to a baseline survey, and receive remote patient monitoring devices and instructions to take home with them (home blood pressure monitor, wrist-worn sensor to track sleep activity, and associated apps)
- receive a random allocation to one of two groups: control condition (receive cash incentives at the end of the study for measuring blood pressure as instructed) or intervention condition (receive weekly cash incentives throughout the study for measuring blood pressure as instructed)
- use remote patient monitoring devices during a two month study period, receive weekly reports on adherence to blood pressure monitoring, and receive weekly financial incentives (intervention condition only)
- attend one follow-up visit at 2 months to measure their blood pressure, complete a follow-up survey, return the remote patient monitoring devices, and receive financial incentives for blood pressure monitoring (control condition only)
Researchers will compare the immediate and delayed incentive groups to see if there are differences in blood pressure monitoring adherence rates and blood pressure control.
- Conditions
- Hypertension, Health Behavior, Healthcare Patient Acceptance, Patient Engagement, Adherence, Patient
- Being tested
- Remote Patient Monitoring, Self-monitoring of hypertension-related factors, Immediate financial incentives, Delayed financial incentives
- Keywords
- preventive healthcare, patient financial incentives, federally qualified health center (FQHC), remote patient monitoring (RPM), health services
- Medical subject headings
- Hypertension, Health Behavior, Patient Acceptance of Health Care, Patient Participation, Patient Compliance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Remote Patient MonitoringBehavioural
Participants will be given a home blood pressure machine and instructed to take their blood pressure twice/day (once in the morning and once at night) for the duration of the 2-month study. Blood pressure values will be immediately available in their patient-facing portal accessible via smartphone app, and patients will receive weekly feedback reports on their adherence to the home blood pressure monitoring protocol. Patients' blood pressure values will also be accessible to their clinical care team via an administrator portal, which will alert clinicians of any values above or below pre-specified clinical thresholds.
Self-monitoring of hypertension-related factorsBehavioural
As part of self-monitoring of hypertension-related factors, the blood pressure monitoring patient-facing app will also prompt patients daily to report whether or not they took their blood pressure medication. in addition, participants will be provided with a wrist-worn sensor and instructed to wear it at night to track their sleep activity. Data on sleep activity will be available to patients through a separate patient-facing app accessible on their smartphone.
Immediate financial incentivesBehavioural
Weekly financial incentives for measuring their blood pressure as instructed (up to $25/week: $5/day for up to 5 days/week)
Delayed financial incentivesBehavioural
Financial incentives for measuring their blood pressure as instructed in one payment at the end of the study (up to $25/week: $5/day for up to 5 days/week)
| Study group | Role | What they receive |
|---|---|---|
| Immediate Financial Incentives for BP monitoring | Experimental | * instructions for participating in a 2-month remote patient monitoring program
* home blood pressure monitor and associated smartphone app, which includes a module for logging medication-taking
* wrist-worn sensor and associated smartphone app
* weekly adherence feedback to home blood pressure monitoring
* immediate financial incentives for home blood pressure monitoring distributed weekly Receives: Behavioral: Remote Patient Monitoring; Behavioral: Self-monitoring of hypertension-related factors; Behavioral: Immediate financial incentives |
| Delayed Financial Incentives for BP monitoring | Active comparator | * instructions for participating in a 2-month remote patient monitoring program
* home blood pressure monitor and associated smartphone app, which includes a module for logging medication-taking
* wrist-worn sensor and associated smartphone app
* weekly adherence feedback to home blood pressure monitoring
* delayed financial incentives for home blood pressure monitoring distributed at the end of the study Receives: Behavioral: Remote Patient Monitoring; Behavioral: Self-monitoring of hypertension-related factors; Behavioral: Delayed financial incentives |
What is being measured
The primary outcome is the main question the study is designed to answer.
Between-group difference in weekly adherence to blood pressure monitoring
Weekly adherence to blood pressure monitoring will be defined as the number of days that the participant used the home blood pressure monitor at least once, captured in the blood pressure monitoring app usage data.
Measured: 8 weeks
Secondary outcomes (4)
Between-group mean difference in change in systolic blood pressure
Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines.
Measured: 8 weeks
Between-group mean difference in change in diastolic blood pressure
Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines.
Measured: 8 weeks
Between-group difference in the proportion with blood pressure control (<130/80 mm Hg)
Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines. Blood pressure control will be defined as systolic <130 mm Hg and diastolic <80 mm Hg.
Measured: 8 weeks
Between-group difference in the proportion with systolic blood pressure control (<130 mm Hg)
Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines. Systolic blood pressure control will be defined as systolic <130 mm Hg.
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2024
- Study start22 May 2024
- Primary completion11 Sep 2025
- Study completion11 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tulane University
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Responsible party
- Sponsor
- Investigators
- Marie Krousel-Wood, MD, MSPH, Principal investigator, Tulane University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06195839
- Sponsor's protocol ID
- 2020-1600-BENH
- Acronym
- BENEFIT-H
- Status last verified
- Sep 2025
- First submitted
- 20 Dec 2023
- Last updated
- 17 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Building Engagement Using Financial Incentives Trial - Hypertension
- ClinicalTrials.gov ID
- NCT06195839
- Acronym / sponsor ID
- BENEFIT-H / 2020-1600-BENH
- Conditions
- Hypertension, Health Behavior, Healthcare Patient Acceptance, Patient Engagement, Adherence, Patient
- Keywords
- preventive healthcare, patient financial incentives, federally qualified health center (FQHC), remote patient monitoring (RPM), health services
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Tulane UniversityUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- 22 May 2024 (actual)
- Primary completion
- 11 Sep 2025 (actual)
- Study completion
- 11 Sep 2025 (actual)
- First posted
- 8 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQHCs). The main questions it aims to answer are:
- Do patients randomized to receive financial incentives on a weekly basis during the study (immediate) have better adherence to blood pressure self-monitoring compared to patients randomized to receive financial incentives at the end of the study (delayed)?
- Do patients randomized to immediate financial incentives have better blood pressure control compared to patients randomized to delayed incentives?
Participants will:
- attend a baseline visit to measure blood pressure, respond to a baseline survey, and receive remote patient monitoring devices and instructions to take home with them (home blood pressure monitor, wrist-worn sensor to track sleep activity, and associated apps)
- receive a random allocation to one of two groups: control condition (receive cash incentives at the end of the study for measuring blood pressure as instructed) or intervention condition (receive weekly cash incentives throughout the study for measuring blood pressure as instructed)
- use remote patient monitoring devices during a two month study period, receive weekly reports on adherence to blood pressure monitoring, and receive weekly financial incentives (intervention condition only)
- attend one follow-up visit at 2 months to measure their blood pressure, complete a follow-up survey, return the remote patient monitoring devices, and receive financial incentives for blood pressure monitoring (control condition only)
Researchers will compare the immediate and delayed incentive groups to see if there are differences in blood pressure monitoring adherence rates and blood pressure control.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Immediate Financial Incentives for BP monitoring | Experimental | Behavioral: Remote Patient Monitoring, Behavioral: Self-monitoring of hypertension-related factors, Behavioral: Immediate financial incentives* instructions for participating in a 2-month remote patient monitoring program * home blood pressure monitor and associated smartphone app, which includes a module for logging medication-taking * wrist-worn sensor and associated smartphone app * weekly adherence feedback to home blood pressure monitoring * immediate financial incentives for home blood pressure monitoring distributed weekly |
| Delayed Financial Incentives for BP monitoring | Active comparator | Behavioral: Remote Patient Monitoring, Behavioral: Self-monitoring of hypertension-related factors, Behavioral: Delayed financial incentives* instructions for participating in a 2-month remote patient monitoring program * home blood pressure monitor and associated smartphone app, which includes a module for logging medication-taking * wrist-worn sensor and associated smartphone app * weekly adherence feedback to home blood pressure monitoring * delayed financial incentives for home blood pressure monitoring distributed at the end of the study |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age ≥40 years
- receive care at a participating FQHC
- taking blood pressure medication
- uncontrolled blood pressure at most recent clinic visit (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg)
- ability to understand and speak English
Key exclusion criteria (2 listed)
- currently participating in another clinical trial or research study on blood pressure, medication-taking, or sleep
- unable or unwilling to give informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Remote Patient MonitoringParticipants will be given a home blood pressure machine and instructed to take their blood pressure twice/day (once in the morning and once at night) for the duration of the 2-month study. Blood pressure values will be immediately available in their patient-facing portal accessible via smartphone app, and patients will receive weekly feedback reports on their adherence to the home blood pressure monitoring protocol. Patients' blood pressure values will also be accessible to their clinical care team via an administrator portal, which will alert clinicians of any values above or below pre-specified clinical thresholds. | Behavioural | Delayed Financial Incentives for BP monitoring, Immediate Financial Incentives for BP monitoring |
| Self-monitoring of hypertension-related factorsAs part of self-monitoring of hypertension-related factors, the blood pressure monitoring patient-facing app will also prompt patients daily to report whether or not they took their blood pressure medication. in addition, participants will be provided with a wrist-worn sensor and instructed to wear it at night to track their sleep activity. Data on sleep activity will be available to patients through a separate patient-facing app accessible on their smartphone. | Behavioural | Delayed Financial Incentives for BP monitoring, Immediate Financial Incentives for BP monitoring |
| Immediate financial incentivesWeekly financial incentives for measuring their blood pressure as instructed (up to $25/week: $5/day for up to 5 days/week) | Behavioural | Immediate Financial Incentives for BP monitoring |
| Delayed financial incentivesFinancial incentives for measuring their blood pressure as instructed in one payment at the end of the study (up to $25/week: $5/day for up to 5 days/week) | Behavioural | Delayed Financial Incentives for BP monitoring |
Primary outcome
Between-group difference in weekly adherence to blood pressure monitoring
Time frame: 8 weeks
Weekly adherence to blood pressure monitoring will be defined as the number of days that the participant used the home blood pressure monitor at least once, captured in the blood pressure monitoring app usage data.
4 secondary outcomes
Between-group mean difference in change in systolic blood pressure
Time frame: 8 weeks
Between-group mean difference in change in diastolic blood pressure
Time frame: 8 weeks
Between-group difference in the proportion with blood pressure control (<130/80 mm Hg)
Time frame: 8 weeks
Between-group difference in the proportion with systolic blood pressure control (<130 mm Hg)
Time frame: 8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Sep 2025.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marie Krousel-Wood, MD, MSPH principal investigator
Tulane University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Remote Patient Monitoring, Self-monitoring of hypertension-related factors and Immediate financial incentives in people with Hypertension and Health Behavior, run by Tulane University at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Between-group difference in weekly adherence to blood pressure monitoring (time frame: 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2025.